Beyond phosphate binding: the effect of binder therapy on novel biomarkers may have clinical implications for the management of chronic kidney disease patients.
Striker
Gary E
GE
Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. gary.striker@mssm.edu
D015415:Biomarkers / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy*; D010710:Phosphates / Q000378:metabolism; D051436:Renal Insufficiency, Chronic / Q000503:physiopathology / Q000628:therapy*
D015415:Biomarkers; D010710:Phosphates